Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-012261
Filing Date
2020-05-07
Accepted
2020-05-07 17:25:24
Documents
2
Period of Report
2020-05-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 8111
2 EX-24 DOCUMENT attachment1.htm EX-24 4268
  Complete submission text file 0000899243-20-012261.txt   13687
Mailing Address 25 BLACK HAWK IRVINE CA 92603
Business Address
Nark Ted C (Reporting) CIK: 0001316851 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38485 | Film No.: 20857753

Mailing Address 400 CROSSING BOULEVARD 3RD FLOOR BRIDGEWATER NJ 08807
Business Address (908) 947-3120
Amneal Pharmaceuticals, Inc. (Issuer) CIK: 0001723128 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations